Copying Tyler Van Buren's trades since 2016 and holding each position for 1 Year would result in 51.87% of your transactions generating a profit, with an average return of 11.4% per rating.
The most profitable rating made by Tyler Van Buren
Tyler Van Buren's Stock Coverage
Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
ISEE
IVERIC bio
Dec 12, 2016
Hold
Downgraded
―
6Ratings
―
0.00%
ALDR
Alder Biopharmaceuticals
Sep 26, 2017
Buy
Initiated
―
1Ratings
―
0.00%
NEOS
Neos Therapeutics
Oct 26, 2017
Buy
Reiterated
―
3Ratings
―
0.00%
AERI
Aerie Pharma
Nov 09, 2017
Buy
Reiterated
―
4Ratings
―
0.00%
LOXO
Loxo Oncology
Jan 07, 2019
Buy
Reiterated
―
7Ratings
―
0.00%
OYST
Oyster Point Pharma
Aug 05, 2020
Buy
Reiterated
―
4Ratings
-46.30%
MNTA
Momenta Pharma
Aug 10, 2020
Buy
Reiterated
―
5Ratings
―
0.00%
EIDX
Eidos Therapeutics
Oct 05, 2020
Hold
Downgraded
―
6Ratings
―
0.00%
OTIC
Otonomy
Feb 22, 2021
Buy
Reiterated
―
8Ratings
-38.75%
TCRR
TCR2 Therapeutics
Mar 11, 2021
Buy
Reiterated
―
4Ratings
-64.53%
List of latest recommendations made by Tyler Van Buren. Click to expand and see Tyler Van Buren's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Tyler Van Buren activity FAQ
What is the performance of Tyler Van Buren's recommendations?
The percentage of profitable recommendations made by Tyler Van Buren is 52%, and the average return per transaction is 11.40%.
What stocks does Tyler Van Buren cover?
Tyler Van Buren mostly covers GILD ,REGN ,MRNA stocks.
What was Tyler Van Buren's most profitable rating?
Tyler Van Buren’s most profitable ratings was a buy on OLMA stock on Mar 24, 2025 - Today. The return on the trade was +409.40%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here